Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer - eBioMedicine
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
Frontiers | Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management
Translational advances in pancreatic ductal adenocarcinoma therapy | Nature Cancer
Biomedicines | Free Full-Text | Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities | Journal of Experimental & Clinical Cancer Research | Full Text
Cancers | Free Full-Text | Mucins and Pancreatic Cancer
Molecular Events in the Natural History of Pancreatic Cancer: Trends in Cancer
Cells | Free Full-Text | Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers
Genetic progression model of pancreatic carcinogenesis. The main... | Download Scientific Diagram
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response | Cell Discovery
Pancreatic cancer: the role of molecular markers in diagnosis and management. | Semantic Scholar
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Frontiers | Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
High‐grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF‐1 | EMBO reports
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
IJMS | Free Full-Text | Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance?
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
Oncotarget: Prognostic and predictive factors | EurekAlert!
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
Targeting Multiple Effector Pathways in Pancreatic Ductal Adenocarcinoma with a G-Quadruplex-Binding Small Molecule | Journal of Medicinal Chemistry
Pancreatic cancer: the role of molecular markers in diagnosis and management. | Semantic Scholar
Molecular Pathology and Biomarkers of Pancreatic Ductal Adenocarcinoma | Encyclopedia MDPI
Molecular biology in pancreatic ductal adenocarcinoma: implications for future diagnostics and therapy | SpringerLink
PANCREATIC CANCER :: Molecular pathology of pancreatic diseases
